Insider Transactions in Q3 2020 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 24
2020
|
Christopher R. Fenimore VP Controller |
BUY
Bona fide gift
|
Indirect |
50
+50.0%
|
-
|
|
Sep 24
2020
|
Christopher R. Fenimore VP Controller |
SELL
Bona fide gift
|
Indirect |
50
-100.0%
|
-
|
|
Sep 22
2020
|
Michael S Brown Director |
SELL
Open market or private sale
|
Indirect |
1,000
-9.66%
|
$552,000
$552.36 P/Share
|
|
Sep 22
2020
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
5,090
-88.78%
|
$2,809,680
$552.36 P/Share
|
|
Sep 22
2020
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,090
+37.77%
|
$1,924,020
$378.82 P/Share
|
|
Sep 22
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
20
-0.35%
|
$11,040
$552.36 P/Share
|
|
Sep 21
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
16,554
-10.54%
|
$9,088,146
$549.63 P/Share
|
|
Sep 21
2020
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,574
+26.78%
|
$6,231,824
$376.35 P/Share
|
|
Sep 01
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.05%
|
$60,300
$603.76 P/Share
|
|
Aug 31
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
10,000
-3.31%
|
$6,120,000
$612.43 P/Share
|
|
Aug 31
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
4,672
-24.45%
|
$2,873,280
$615.04 P/Share
|
|
Aug 28
2020
|
Christine A Poon Director |
SELL
Open market or private sale
|
Direct |
40,000
-33.78%
|
$24,040,000
$601.02 P/Share
|
|
Aug 28
2020
|
Christine A Poon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+42.68%
|
$1,160,000
$29.43 P/Share
|
|
Aug 27
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
5,328
-12.84%
|
$3,271,392
$614.87 P/Share
|
|
Aug 27
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+19.27%
|
$520,000
$52.03 P/Share
|
|
Aug 25
2020
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Open market or private sale
|
Direct |
27,109
-13.03%
|
$16,563,599
$611.98 P/Share
|
|
Aug 25
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Indirect |
1,000
-21.28%
|
$612,000
$612.0 P/Share
|
|
Aug 25
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
32,750
-2.68%
|
$19,879,250
$607.46 P/Share
|
|
Aug 25
2020
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,750
+11.6%
|
$3,480,750
$273.67 P/Share
|
|
Aug 24
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
20,037
-1.74%
|
$11,901,978
$594.91 P/Share
|
|
Aug 24
2020
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,037
+8.77%
|
$1,776,549
$177.82 P/Share
|
|
Aug 21
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
1,000
-15.05%
|
$617,000
$617.18 P/Share
|
|
Aug 21
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
19,963
-4.58%
|
$12,097,578
$606.57 P/Share
|
|
Aug 21
2020
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,963
+4.27%
|
$1,165,671
$117.47 P/Share
|
|
Aug 20
2020
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Payment of exercise price or tax liability
|
Direct |
47,891
-50.41%
|
$29,405,074
$614.09 P/Share
|
|
Aug 20
2020
|
Daniel P Van Plew EVP & General Mgr Industrial O |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+44.12%
|
$13,425,000
$179.13 P/Share
|
|
Aug 20
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
21,000
-1.89%
|
$12,957,000
$617.45 P/Share
|
|
Aug 20
2020
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.04%
|
$570,000
$57.11 P/Share
|
|
Aug 20
2020
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-6.68%
|
$612,000
$612.15 P/Share
|
|
Aug 20
2020
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+6.26%
|
$342,000
$342.93 P/Share
|
|
Aug 11
2020
|
P Roy Vagelos Director |
SELL
Open market or private sale
|
Indirect |
33,460
-3.79%
|
$20,109,460
$601.32 P/Share
|
|
Aug 04
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
696
-2.82%
|
$455,184
$654.46 P/Share
|
|
Aug 03
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.02%
|
$64,000
$640.5 P/Share
|
|
Jul 27
2020
|
George Yancopoulos President and Chief Scientific |
SELL
Bona fide gift
|
Indirect |
57,465
-100.0%
|
-
|
|
Jul 21
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
391
-0.78%
|
$254,932
$652.75 P/Share
|
|
Jul 21
2020
|
Christopher R. Fenimore VP Controller |
SELL
Open market or private sale
|
Direct |
3,709
-1.46%
|
$2,384,887
$643.32 P/Share
|
|
Jul 20
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,413
-12.87%
|
$4,855,515
$655.57 P/Share
|
|
Jul 20
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+12.86%
|
$4,054,500
$477.66 P/Share
|
|
Jul 20
2020
|
Christopher R. Fenimore VP Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
12,224
+18.92%
|
$1,405,760
$115.58 P/Share
|
|
Jul 20
2020
|
Christopher R. Fenimore VP Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
6,291
-24.89%
|
$4,120,605
$655.57 P/Share
|
|
Jul 14
2020
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
6,309
-0.61%
|
$3,949,434
$626.69 P/Share
|
|
Jul 14
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
579
-2.36%
|
$370,560
$640.5 P/Share
|
|
Jul 13
2020
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
6,691
-12.18%
|
$4,168,493
$623.98 P/Share
|
|
Jul 13
2020
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+19.13%
|
$390,000
$30.63 P/Share
|
|
Jul 13
2020
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
8,000
-1.24%
|
$5,016,000
$627.1 P/Share
|
|
Jul 09
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,421
-8.98%
|
$1,554,282
$642.46 P/Share
|
|
Jul 09
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+10.01%
|
$1,197,000
$399.66 P/Share
|
|
Jul 08
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
1,160
-0.39%
|
$744,720
$642.09 P/Share
|
|
Jul 07
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,340
-17.44%
|
$7,257,600
$640.88 P/Share
|
|
Jul 07
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+15.59%
|
$5,962,500
$477.66 P/Share
|